Cancel
Anthony Abbruscato
Vice President, Clinical Development
@
Stealth BioTherapeutics
j28v99q.5gxv0wizpi@0kxi1jf54.kfi
Sign up to see email
Known information
- Received a Bachelor of Science and Doctor of Pharmacy degrees from Northeastern University.
- Completed residency training at NYU Langone Hospital, Long Island.
- Completed a post-doctoral industry Fellowship at the Novartis Institutes for Biomedical Research in translational oncology.
- Holds a board certification as a Pharmacotherapy Specialist.
- Has held a faculty appointment at Massachusetts College of Pharmacy and Health Sciences University.
- Has close to 10 years of experience between clinical practice, academia, and industry.
- Has held positions in translational medicine, clinical pharmacology, early clinical development, and late-stage clinical development across both large pharmaceutical and biotechnology companies.
About Stealth BioTherapeutics
Stealth BioTherapeutics develops therapies for mitochondrial dysfunction related to genetic diseases and aging, with a focus on elamipretide and SBT-272 in clinical studies.
Report inaccurate information
